We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Biotech / MedicalGMXX - GENEMAX CORP

Previous 10 Next 10 
To: afrayem onigwecher who started this subject8/4/2004 10:47:00 PM
From: StockDung
   of 978

From: Bill DeMorrow (
Subject: Waaco Kids Last Roundup
This is the only article in this thread
View: Original Format
Newsgroups: misc.invest.stocks
Date: 1996/07/05

Date: Fri, 5 Jul 1996 20:55:22 GMT






'SOMETHING INTRIGUING HAPPENED to the stock of Guardian Insurance Financial
Services back in January. In the universe of news sources available to
investment professionals, such as Dow Jones News/Retrieval Service and
Bloomberg Business News, nothing significant was brewing,' noted Business
Week in its feature financial story on May 27.

'Yet, for no apparent reason, Guardian stock began to climb --2 1/8 on Jan.
10, 2 3/4 on Jan. 16, then 3 and 4 1/2 and up to 6 on Jan. 24.

'What happened? A press release issued by the company at month's end said
the rise was 'partly attributable to a favorable review by an electronic
newsletter.' But to followers of a band of stock traders on the Internet,
there was no 'partly'' about it ... the Waaco Kid Hot Stocks Forum had
picked Guardian.

'And when the Waaco Kid speaks, investors listen--and buy.'


'The Waaco Kid works simply. Every member--or ``co-editor'' ... has the
right to distribute stock suggestions to all the other members of the list.
A small nucleus of members ... makes ``picks,'' or formal recommendations

'Wall Street pros have long reveled in their power to move the market. Now
it's the little guy's turn,' concluded the article.


Members of the Waaco Kid's Hot Stocks Forum have another unique edge.
Co-Editors have the right, until all slots are gone, to also join the Waaco
Kid's Hot Stocks Investment Club, whose participants have to agree their
intent is to 'lose all my money'. A pioneer on-line investment club, and
a member of both the NAIC and NCII, the 'Kid', as the Club is widely known
on the Street when it regularly announces where it is positioning, has
recently reorganized to become even more aggressive. The elected President
of the 'Club' is known throughout the internet by his trademark moniker
'Billy the Kid' (who else!?).

Members of the Forum, as it is called by co-editors, are also all invited
to participate in the 'picks' through two committees -- the 'Pick
Evaluation Team', and the 'Newsletter Evaluation Team'. The PET looks at
undervalued, underdisclosed, undertraded, underfollowed and underdiscovered
stocks which are often trading below book value or low P/E ratios, to find
ones where management is entering an aggressive era or where news and
developments which can drive the stock price appear imminent!
Members get close to the management -- and sometimes management will agree
to host an on-line
conference call for Forum members to learn first-hand about the company's
plans and ambitions.

The NET group develops exchanges with newsletter editors and publishers so
the Forum can be on the front lines when new hot newsletter picks are
published! The Forum's 'pick' sources have included the Dick Davis
Digest, Business Week, Tomorrow's Stocks, Strategic Investor, The Phantom,
Pegasus First Call, the Kon-Lin Letter, Today's Investor, the Bowser
Report, SSH Guru, Ground Floor, and the Red Chip Review, to name a few.

Overall, for 50 'picks', the Kid's stocks have never once fallen back
(prior to rising) after a 'pick', and have risen from a low of 2% to a high
of 775%, leaving an enviable average gain of 101% for 50 selections.


What's next for the 'Kid'? The Waaco Kid is now a prominent fixture on
the i.Star-licensed 'MegaSite' [tm] for financial information, news and
features at

As a caricature, 'the Waaco Kid' is a can't walk straight and chew gum at
the same time' rascal who 'HYPNOtyzes' his stock selections, and whose
worldwide 'Waaco Sightings', which websurfers can post, are legendary.
Recently, Waaco began casting about at the New York Licensing Show for a
licensing agent, and may one day be featured in your favorite comic book or
in his own full-length animated motion picture. Who knows?

But for now, he is rapidly expanding, with more and more features that
already created comparisons in Business Week with 'The Motley Fool'; and
when the all-new '' website is fully loaded with graphics
sometime this coming week, he will also have his own 'Waaco's Galleria' of
5U companies in a new soon-to-be announced arrangement with another
well-known internet organization, more emerging details of his as
yet-untold exploits with the likes of Pecos Bill and Judge Roy Bean, and,
are you ready
... a 24-hour on-line investment Chat room just for the 'Kids'!

When the 'Kid's' picks and alerts are published, the 'Kid' imposes a
24-hour moratorium on all of its co-editors to prevent hysterical buy-ins
by individuals unexposed to the educational aspects of the Forum --- the
'Textbook Investment Method (TIM)', etc.

Afterwards, the 'Kid' announces its selections to the Street through its
thousands of trader stations and other electronic distribution networks, so
that over time, the 'Kid's valuations come to be recognized and accepted by
professional traders and institutions, where those valuations, to date,
have been proven time and time again.

Often the 'Kid' is way ahead of the curve, however. For example, Business
Week's example, Guardian (now Genesis), via the ticker symbol GIFS, as an
emerging reorganization at the time the 'Kid' stumbled upon it, didn't even
know its own book value at the time. It's over $14, and growing! Yet,
after the initial flurry -- the price easily shattered the Kid's target --
the Street pushed its price back down because the book value isn't even yet
verified by a Street-recognized accounting firm. Now, GIFS is preparing
to become fully reporting, apply for a full listing and is expected, in
time to announce that its new recognized accounting firm, rumored to be
Ernst & Co., has validated its figures.

Where do you think that stock will settle when that happens? So that is a
classic Forum 'positioning' pick. No rocket science. Just hard work,
diligence, and patience.


The Kid's full record, with all of his sources, will be posted this weekend
on the website, or you can request it by e-mailing!


More recently that patience and belief in its valuation paid off when
Quantum Learning Systems (QLSI) rocketed 775% after weeks of patient
trading by the Forum. Even though QLSI burst through the Kid's target,
Waaco recently sobered up to put down a riot when some ornery varmints
threatened those gains. That became quickly known as 'The Shootout at the
AOL Corral', and only added to Waaco's already Waacko legend and ardent
following. A believer in truth, justice and the small investor's rights,
Waaco just deputized hisself and stepped right in with both guns blazing.

Some were surprised to see that he still had it in him, but those of us who
have followed ol Waacky's explOits for the past year are often amazed but
never surprised at any thing that critter might do.

One thing for sure, he ain't much to look at but he sure as heck knows how
to pick them


If you want to be inside where the action is, and to see all the new
developments as they occur via a stream of daily e-mail transmissions and
discussions between co-editors sent right to your e-mail box AS THE
DEVELOPMENTS OCCUR, you need only request the Financial Independence Day
Special via e-mail to to get the special forum giving you
3 months of the Forum for only $10.

This special lasts only until midnight Sunday. As a special bonus, for the
rest of July you will also receive, absolutely free, the daily
HotStocks@StreetLevel which over the past six months has posted more than
500 stock symbols, from one to six a day! These have an average daily
run-up of 6% and a 3-month average gain of 25%. About five of these
actually DECLINED after posting. HSSL regularly appears on trader
stations, Bloombergs, network radio, fax, e-mail, websites and JagNotes.
It's priced at $60 per month, and is yours free for the rest of July if you
subscribe to become a Waaco Kid co-editor.
The Kid is regularly $10 per month, but it's yours through this weekend
only, as we begin to build circulation, distribution and an even greater
small investor powerhouse, for $10 for a full three months.

For full details and the Kid's record, write and get
ready to join the Waacky and Wonderful World of the Waaco Kid!

This special is available only via e-mail, and only thru midnight July 7.

It is NOT available through our phone ordering service. Thanks.


-- [c] Copyright, 1996, by StreetLevel [tm], a division of NetCapital
Corporation, located on the Web at, rated 4-STAR
by the monthly magazine ''. All terms and conditions for usage
are strictly enforced and contained in the 'Registration Agreement' found
on our website.

StreetLevel [tm] is the exclusive electronic distributor for
HotStocks@StreetLevel [tm] / 'HSSL' ($60 monthly e-mail, $75 fax); The
Waaco Kid's Hot Stocks Forum [tm] / 'HSF' ($10 monthly);
StockClock@StreetLevel [tm] / 'SCSL' ($8 monthly); and IRx / Investors
Research Journal [tm] ($10 monthly beginning Oct / 96).

All subscriptions include membership in Investors Research Institute (IRI).
Call New York Society of Security Analysts at 212-912-9249 for
reservations to 2nd Tuesday IRI/NYSSA Wall Street Newsmaker Luncheon
(beginning Sept. 10 in World Trade Center).

All subscriptions are automatically billed semi-annually at then-current
prices (as posted here) at each next regularly scheduled billing date (no
refunds). Subscribers may opt for annual billing to lock in then-current
prices and bonuses. Currently, HSSL subscribers receive all services and
publications as bonus. HSF subscribers also receive StockClock [tm]. All
StreetLevel [tm] products and publications are informational only, and
opinions of each writer, who should be assumed to hold positions, and
should never be construed as 'buy' or 'sell' recommendations for any

For a 2-Week Free Trial call 1-800-241-9111, Ext. 329, or e-mail or Fax 516-427-4867. To affect billing changes or
unsubscribe, please e-mail or fax only. Thank you.

Bill DeMorrow
If this were a logical world men would ride side-saddle!

Share RecommendKeepReplyMark as Last Read

To: afrayem onigwecher who started this subject8/4/2004 11:02:07 PM
From: StockDung
   of 978
To:Yuri Aminov who started this subject
From: buzzlite Thursday, Dec 26, 2002 11:51 PM
View Replies (1) | Respond to of 8000

Periodically I search the web to see if there is any justice re the gifs scam. Haven't found any justice yet, but it's always interesting to me.
The esteemed former editor of waaco kid seems to be here.
Then I searched Mohamed Zayed and found this. Surely it can't be the same one.

Share RecommendKeepReplyMark as Last Read

To: StockDung who wrote (929)8/14/2004 3:23:43 PM
From: afrayem onigwecher
   of 978
Concorde America, Inc. Disclaims Prior Information Releases

Share RecommendKeepReplyMark as Last ReadRead Replies (2)

To: StockDung who wrote (925)12/18/2004 1:02:38 PM
From: tonto
   of 978
Gayle is a punk. His involvement internally at GIFS is well known. I have some documents regarding his communications...(s)

When GIFS was about to crumble and he was provided with the truth, he completely ignored it because he was invested and involved...

So, then the articles started about me being a jewel thief, corporate spy, on my way to Mexico...lolol...instead the offices at GIFS were raided and the company was shut down.

Zayed and Gayle were tight...

Share RecommendKeepReplyMark as Last ReadRead Replies (1)

To: tonto who wrote (932)12/18/2004 1:11:17 PM
From: scion
   of 978

To: TheTruthseeker who wrote (88832) 12/18/2004 12:05:16 PM
From: scionist Read Replies (1) of 88852

Message 20869325



10. Plaintiff Mark F. Backhaus purchased shares of Streamedia common stock pursuant to the Company’s Prospectus filed in connection with its IPO, which was commenced on December 22, 1999. His signed certification, executed pursuant to the federal securities laws, is attached hereto.

11. Streamedia is a Delaware corporation that claims to provide website owners and content publishers with cost-effective services and tools for streaming, or broadcasting, live and on demand video and audio content over the Internet. The Company also operates a so-called .broadcast content website,. Bijou Cafe, at The Company claims to have two primary components: it acts as an Internet content publisher and broadcaster, and as a business-to-business service bureau, to assist other businesses to publish and broadcast their content on the Web.

12. Defendant James D. Rupp ("Rupp") was the President and Chief Executive Officer and a director of the Company from its inception until October of 2000, when he resigned his management role, though he continued to serve as a director. In addition, Rupp signed the Prospectus filed in connection with the Company’s IPO. Rupp has been President and CEO of Capital Markets Communications Corporation a publisher of a number of Internet micro-cap stock
promotion newsletters including StreetSignals, TradeSignals, PowerSignals, AmexWire and the Waaco Kid.s Forum, among others.

13. Defendant Gayle Essary (.Essary.) was a founder, the Chairman and Vice President of the Company from its inception until his termination by the Company in March of 2001. In addition, Essary signed the Prospectus filed in connection with the Company’s IPO. Essary has also been Chairman of Investors Research Institute, an organization aimed at promoting the stock of microcap companies to individual investors. He is, and has been, an executive officer of several other companies that operate Internet stock promotion newsletters including HotStocks@StreetLevel, the Waaco Kid.s Forum and a number of others.

14. Defendant Walter Hollenberg ("Hollenberg") was the Vice President of Technology for Streamedia from July 1999 until sometime in 2000 and is listed in the Prospectus as an executive officer of the Company.

15. Defendant Nicholas Malino ("Malino") was the Chief Financial Officer of the Company beginning in November of 1998 and also served as Executive Vice President and Chief Operating Officer from August of 1999 until his resignation in October of 2000. In addition, Malino signed the Prospectus filed in connection with the Company’s IPO.

16. Defendant Henry Siegel (.Siegel.) was at all relevant times a director of the Company and in October of 2000, Seigel became the Chief Executive Officer of the Company. In addition,
Seigel signed the Prospectus filed in connection with the Company’s IPO.

17. Defendants Robert J. Wussler and David J. Simonetti were, at all relevant times, directors of Streamedia, and they each signed the Prospectus filed in connection with the Company’s IPO.

18. For purposes of this Complaint, the individual defendants identified in ¶¶12-17 shall be referred to herein as the "Individual Defendants."

19. Defendant Capital West Securities, Inc. (.Capital West.) is an Oklahoma corporation principally located at 211 North Robinson Street, Suite 200, Oklahoma City, OK, 73102-7101. Capital West is an NASD registered broker/dealer and acted as a lead underwriter and as corepresentative
for the underwriting group in the IPO.

20. Defendant Institutional Equity Corporation (.IEQ.) is an Oklahoma corporation principally located at 5910 North Central Expressway Ste. 1480, Dallas, TX 75206. IEQ is an NASD registered broker/dealer and acted as a lead underwriter and as co-representative for the underwriting group in the IPO.

21. Defendant Kashner Davidson Securities Corporation (.Kashner.) is a Florida corporation principally located at 77 South Palm Avenue, Sarasota, FL 34236-7724. Kashner is an NASD registered broker/dealer and acted as an underwriter for the IPO.

22. Defendant Nutmeg Securities, Ltd. (.Nutmeg.) is a Connecticut corporation principally located at 495 Post Road East, Westport, Ct 06880. Nutmeg is an NASD registered broker/dealer and acted as an underwriter for the IPO.

23. Defendant Schneider Securities, Inc. (.Schneider.) is a Colorado corporation principally located at 1120 Lincoln Street, Suite 900, Denver, CO, 80203. Schneider is an NASD registered broker/dealer and acted as an underwriter for the IPO.

24. Defendant Westport Resources Investment Services, Inc. (.Westport.) is a Connecticut corporation principally located at 315 Post Road West, Westport, CT 06880-4645. Westport is an NASD registered broker/dealer and acted as an underwriter for the IPO.

25. Defendant The Agean Group, Inc. (.Agean.) is a Florida corporation principally located at One South Ocean Blvd. Suite 300, Boca Raton, FL, 33432. Agean is an NASD registered broker/dealer and acted as an underwriter for the IPO.

26. Defendant Smith, Moore & Co. (.Smith.) is a Missouri corporation principally located at 400 Locust Street, St. Louis, MO 63102. Smith is an NASD registered broker/dealer and acted as an underwriter for the IPO.

27. Defendant Global Capital Securities Corporation, formerly known as EBI Securities Corporation (.Global.) is a Missouri corporation principally located at 6300 South Syracuse Way, Suite 645, Englewood, CO, 80111. Global is an NASD registered broker/dealer and acted as an underwriter for the IPO.

28. For purposes of this Complaint, defendants Capital West, IEQ, Nutmeg, Kashner, Westport, Schneider, Agean, Smith and Global will be referred to herein as the "Underwriter Defendants."

29. The Underwriter Defendants were the underwriters for the IPO, and were primarily involved in offering and selling shares of the Company to the public in the IPO.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)

To: scion who wrote (933)12/18/2004 1:16:09 PM
From: tonto
   of 978
They forgot to mention that he claimed he was a confidante of LBJ too...(g) He had this bathroom story that he liked to tell...

Share RecommendKeepReplyMark as Last ReadRead Replies (1)

To: tonto who wrote (934)12/18/2004 1:32:32 PM
From: scion
   of 978
Essary seems to have been a "confidante" of many people....maybe he sees himself as "inside the tent..."

Share RecommendKeepReplyMark as Last ReadRead Replies (2)

To: scion who wrote (935)12/18/2004 1:41:05 PM
From: tonto
   of 978
lol. Essary would talk big through his "media empire", but then would cry about his old beater that he had to drive and he did not want his children to learn through the internet what he truly is...

Share RecommendKeepReplyMark as Last Read

To: afrayem onigwecher who wrote (931)12/29/2004 10:46:57 AM
From: StockDung
   of 978
.IN THE MONEY: GeneMax Naked-Short Suits Dismissed

28 December 2004
Dow Jones News Service
(c) 2004 Dow Jones & Company, Inc.

By Carol S. Remond
A Dow Jones Newswires Column

NEW YORK (Dow Jones)--Two more lawsuits alleging illegal short selling
by brokerage firms have been dismissed without much fanfare.

Biotech company GeneMax Corp. (GMXX) was at the forefront of companies
protesting what they said were unfair attacks by short sellers in late
2002. Back then and through much of 2003, GeneMax and its then-marketing
firm Investor Communications International, or ICI, led a campaign
against naked short selling, or short selling without first borrowing
securities to make delivery.

As part of its campaign, GeneMax filed lawsuits in Canada and in the
U.S. to try to prevent brokerage firms from engaging in naked short

GeneMax filed a lawsuit against Canadian brokerage firms Global
Securities Corp. and Union Securities Corp. in September 2002 in the
Supreme Court of British Columbia. The company alleged that the
brokerages engaged in illegal short selling to manipulate the price of
its shares.

A court order obtained by Dow Jones Newswires shows that suit was
dismissed on Dec. 16. A countersuit filed by Global Securities and Union
Securities was also dismissed.

GeneMax had widened its legal fight with the brokers to U.S. courts in
October 2002 when it filed suit against 11 brokerage firms in the U.S.
District Court for the District of Nevada. That suit was dismissed. But
the company filed another suit in November 2003 that mirrored much of
the illegal short selling allegations it made in its first Nevada suit,
including fraud and racketeering. The original suit named Knight Trading
Group Inc. (NITE), Charles Schwab Corp. (SCH) and nine others and seeks
injunctions to prevent the firms from shorting GeneMax shares and
unspecified damages.

Court documents show that the 2003 Nevada suit was dismissed on Nov. 9.

GeneMax's shares, which topped $20 a share in late 2002, are now trading
at a mere 24.5 cents in very thin trading.

GeneMax's President and Chief Executive Ronald Hanford wasn't
immediately available to comment.

GeneMax was the subject of three "In The Money" columns in 2002 and
2003. Those columns questioned whether insiders would benefit most from
limits on short selling and GeneMax's connection to consultant ICI.
GeneMax terminated its agreement with ICI in late 2003.

In a short sale, a security not owned by the seller is sold in
anticipation of a decrease in the stock's price. In the U.S., NASD
requires that before they engage in short sales for themselves or
clients, firms make an affirmative determination that they can borrow a
security or will be able to provide it for delivery on demand. Market
makers are exempt from the affirmative determination rule when engaged
in "bona fide market making activity" because they provide needed
liquidity to the market. Earlier this year, NASD tightened its
affirmative determination rule, making it harder for Canadian brokerages
to take advantage of the fact that no borrowing requirement exists in
that country.

In September, another suit alleging naked short selling was dismissed
after Jag Media Holdings Inc. (JAGH), which also led the charge against
naked short selling in the U.S., failed to make its case.

Jag Media and Gary Valinoti, the company's former chief executive, sued
more than 100 brokerage firms, investment firms and financial
institutions in July 2002, alleging that they entered into a civil
conspiracy and concert of action to short sell Jag Media's stock. In the
suit, originally filed in the Judicial District Court, Harris county in
Texas and later removed to the U.S. District Court for the Southern
District of Texas, Houston Division, Jag Media alleged that the
financial institutions committed market manipulation and fraud and
violated securities laws.

That case was dismissed by U.S. District Judge Vanessa Gilmore after she
found multiple deficiencies in Jag Media's third amended complaint.
Gilmore found that Jag Media didn't have a viable claim against those

(Carol S. Remond is an award-winning columnist and one of four who write
the "In The Money" feature. Most recently, she shared a 2003 Best of
Business Award from the Society of American Business Editors and Writers
for her role in Dow Jones' team coverage of the Canary Capital mutual
fund trading scandal.)

-By Carol S. Remond; Dow Jones Newswires; 201 938 2074; [ 12-28-04 1742ET ]


Share RecommendKeepReplyMark as Last Read

To: afrayem onigwecher who wrote (931)12/29/2004 11:37:31 AM
From: StockDung
   of 978

"In this respect, it is suggestive that the SEC apparently leaked its complaint about Agora to Remond, who cooperated by writing a story trumpeting the SEC's effort to discredit me and these good companies."

Dear Vantage Point Investor,

You may be as startled and upset as I am by the sudden collapse in the price of GeneMax (GMXX), which has tumbled in the last nine trading days. The question is, why? I can't pretend that I fully understand the answer. But I have a disturbing guess. It appears that the naked short-sellers who have counterfeited millions of GeneMax shares in an attempt to destroy the company have enlisted powerful help.

In theory, the Securities and Exchange Commission is a regulatory body charged with maintaining the integrity of public securities markets in the United States. In reality, the SEC is like any other government agency. It responds to powerful entrenched interests. It abhors bad publicity, rewards its friends and punishes its critics.

Unhappily, the SEC also lies. I know because the SEC field office in Utah has lied about me. And I suspect that these lies are the culmination of a carefully laid plan to discredit GeneMax and punish the company for raising troublesome issues about naked short selling, which has also embarrassed the SEC.

If you have been a subscriber to Vantage Point for any length of time, you are no doubt aware that I am a critic of "electronic counterfeiting," the process by which some investment banks, market makers and broker-dealers drive down the prices of Nasdaq Bulletin Board companies by selling unlimited quantities of shares they don't own. Since stock prices are determined by supply and demand, allowing unlimited counterfeiting of stock essentially guarantees that the stock becomes worthless.

Of course, a company whose shares are worthless won't last long. It is unable to raise money if its stock is worthless. All too often, such small companies are driven into oblivion by electronic counterfeiting. When we are slogging along with a weak economy, I consider it almost criminal negligence that the government would permit investment banks, market makers and broker-dealers to weaken the economy further by destroying small companies that could otherwise be a major fountain of growth.

Why would the government let this happen? I don't think it is necessarily a Grand Conspiracy with a capital "G." But the bad guys have managed to control most of the news about "electronic counterfeiting." And perversely, they also seem to have the regulators on their side.

I had a painful lesson in this reality at the beginning of this week when I learned to my astonishment that the Utah office of the SEC had tarnished my name by accusing me of failing to disclose an interest in two investments that I recommended in Vantage Point Investment Advisory. Their exact charge is as follows:

"Among the issuers promoted in this manner have been GeneMax Corp. and Endovasc Ltd., Inc. DAVIDSON is an officer, director and, indirectly, a substantial shareholder of these two issuers. Neither the soliciting e-mail nor the subsequent company report discloses DAVIDSON's relationship to the companies."

This is total rubbish. I deny any impropriety. Indeed, the charges are remote from the facts.

As you will know if you subscribed to Vantage Point last summer, I fully disclosed my role as a founder, director and officer of GeneMax when I recommended the company and its promising treatment for cancer. And I also disclosed a special relationship with Endovasc. I am not an officer or director of Endovasc. I have a few shares that I received in exchange for assigning my rights in what could be a valuable patent to the company.

To be sure that I wasn't missing something, I had my attorney review the record. He concluded that my disclosures are complete: "I spent this afternoon reviewing Agora marketing copy for Vantage Point and the newsletters and have verified that the charge that you failed to disclose your personal interest in GeneMax is completely false." Agora will be filing a motion to dismiss the SEC's baseless complaint.

I fail to see how anyone of good faith who reviewed the record could possibly construe it as the SEC apparently has. Although I can't prove it, I have concluded that the SEC, or at least some of its personnel, were more offended by my criticism of electronic counterfeiting than they are by the abuse itself -- which causes you and other investors hundreds of billions in losses. In fact, the costs of electronic counterfeiting are much higher than those entailed in the accounting scandals which have garnered so much attention. Nonetheless, instead of correcting these abuses, the SEC has gone out of its way to rope me into a doubtful complaint that they have developed against another Agora publication -- a product to which I have no connection other than a passive one as a minority shareholder in Agora.

Nor do I take it to be entirely a coincidence that while I have recommended more than 30 investments in Vantage Point over the past 16 months, my reputation is being tarred in respect to just two companies, GeneMax and Endovasc. These two companies have one thing in common, in addition to the fact that both have promising medical innovations that could ease much suffering and save many lives. Both have been at the forefront of legal action to combat the abuse of electronic counterfeiting of their shares. But these efforts have hardly earned them the friends they should. Rather than garnering applause, their efforts to confront the abuse of electronic counterfeiting of their shares has made both companies the focus of negative publicity.

In particular, one writer, Carol S. Remond, undertook to paint a negative picture of both companies, publishing what bordered on outright lies. For some reason known only to others, the SEC appears to have adopted Remond's text in defense of the electronic counterfeiters. In this respect, it is suggestive that the SEC apparently leaked its complaint about Agora to Remond, who cooperated by writing a story trumpeting the SEC's effort to discredit me and these good companies.

I wanted to write to you immediately when I got this startling news to tell you that I will not be cowed by these Machiavellian tactics. I will continue to raise important issues of investor protection that the SEC appears to wish to duck. I do so with faith that the truth will eventually triumph, the evil of electronic counterfeiting will be curtailed, and the integrity of public security markets restored.

Or to put it another way, if powerful people are so keen to discredit my criticism of electronic counterfeiting that they will orchestrate an entirely bogus charge of the kind carried on the wires against me this week, that itself indicates that more light needs to be shed on the shadowy activities they are trying to protect.

But, on to the status of your GeneMax holdings... Absolutely nothing about this company or its exciting immunotherapy development has changed and would warrant this share price decline. In fact, in an independent study commissioned by the company, it was determined that if GeneMax were funded as low as at $1.50 per share, and assuming that its products prove to work as well in humans as they have in animals, the present value of the stock would be $420 per share, notwithstanding dilution. GeneMax remains a fundamentally sound company and a tremendous buying opportunity at these levels. I recommend that you increase your GeneMax shares, as well as those in Endovasc (EVSC.OB). And, may I reiterate, I am a shareholder in both companies.

And, if you are as concerned as I am about electronic counterfeiting and its effects on the dynamic young companies that must fuel our country's future growth (as well as your portfolio), I urge you to write your congressman. You can also register your concern with the National Association Against Naked Short Selling (,, which is taking up the fight for companies and investors alike.



Share RecommendKeepReplyMark as Last Read
Previous 10 Next 10